Loading…

Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia

Purpose The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and ado...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric surgery international 2012-12, Vol.28 (12), p.1195-1199
Main Authors: White, Alan D., Othman, Diaa, Dawrant, Michael J., Sohrabi, Soroush, Young, Alastair L., Squire, Roly
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13
cites cdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13
container_end_page 1199
container_issue 12
container_start_page 1195
container_title Pediatric surgery international
container_volume 28
creator White, Alan D.
Othman, Diaa
Dawrant, Michael J.
Sohrabi, Soroush
Young, Alastair L.
Squire, Roly
description Purpose The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL). Methods All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC. Results We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports ( p  
doi_str_mv 10.1007/s00383-012-3213-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1221135258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1221135258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</originalsourceid><addsrcrecordid>eNp1kc1O3TAQha0KVC4_D9ANstRNNyke20mcZYX6g4TEBtaWrz3mhjrJre1QeIi-M44uIFSJjcfS-eaMPYeQT8C-AmPtWWJMKFEx4JXgICr5gaxAirbqFIg9smLQdhUTtToghyndMcaUaLqP5IALaFXXsBX5dzFsgxmzWQek9xjTnKidvUdH8SFjHE2gFsccS73HcVpkkzdYpET9FGm508GM5haHgtHJU7vpg4s4UjM6atwUMC0Oif7t84YaO2ek4XHYbqZ1MCn3lgacfxscenNM9r0JCU-e6xG5-fH9-vxXdXn18-L822VlRctz5cBzyW2t1q3lnVXKdFyCV7KpmapRWIseG0BsXQ3InVXlbCxzSvrOIIgj8mXnu43TnxlT1kNfHhnKJrB8UQPnAKLmtSro5__Qu2le1rJQTSNlLfliCDvKximliF5vYz-Y-KiB6SUrvctKl6z0kpWWpef02XleD-heO17CKQDfAalI4y3GN6PfdX0C2WSh6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266445421</pqid></control><display><type>article</type><title>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</title><source>Springer Link</source><creator>White, Alan D. ; Othman, Diaa ; Dawrant, Michael J. ; Sohrabi, Soroush ; Young, Alastair L. ; Squire, Roly</creator><creatorcontrib>White, Alan D. ; Othman, Diaa ; Dawrant, Michael J. ; Sohrabi, Soroush ; Young, Alastair L. ; Squire, Roly</creatorcontrib><description>Purpose The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL). Methods All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC. Results We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports ( p  &lt; 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall ( p  &lt; 0.001) and for specific complications such as infection ( p  &lt; 0.001) and dislodgement ( p  = 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates. Conclusion When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.</description><identifier>ISSN: 0179-0358</identifier><identifier>EISSN: 1437-9813</identifier><identifier>DOI: 10.1007/s00383-012-3213-4</identifier><identifier>PMID: 23178960</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adolescent ; Catheterization, Central Venous - adverse effects ; Catheterization, Central Venous - instrumentation ; Catheters, Indwelling - adverse effects ; Child ; Child, Preschool ; Equipment Design ; Female ; Humans ; Infant ; Male ; Medicine ; Medicine &amp; Public Health ; Original Article ; Pediatric Surgery ; Pediatrics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Retrospective Studies ; Surgery ; Young Adult</subject><ispartof>Pediatric surgery international, 2012-12, Vol.28 (12), p.1195-1199</ispartof><rights>Springer-Verlag Berlin Heidelberg 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</citedby><cites>FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23178960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>White, Alan D.</creatorcontrib><creatorcontrib>Othman, Diaa</creatorcontrib><creatorcontrib>Dawrant, Michael J.</creatorcontrib><creatorcontrib>Sohrabi, Soroush</creatorcontrib><creatorcontrib>Young, Alastair L.</creatorcontrib><creatorcontrib>Squire, Roly</creatorcontrib><title>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</title><title>Pediatric surgery international</title><addtitle>Pediatr Surg Int</addtitle><addtitle>Pediatr Surg Int</addtitle><description>Purpose The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL). Methods All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC. Results We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports ( p  &lt; 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall ( p  &lt; 0.001) and for specific complications such as infection ( p  &lt; 0.001) and dislodgement ( p  = 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates. Conclusion When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.</description><subject>Adolescent</subject><subject>Catheterization, Central Venous - adverse effects</subject><subject>Catheterization, Central Venous - instrumentation</subject><subject>Catheters, Indwelling - adverse effects</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Original Article</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Young Adult</subject><issn>0179-0358</issn><issn>1437-9813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kc1O3TAQha0KVC4_D9ANstRNNyke20mcZYX6g4TEBtaWrz3mhjrJre1QeIi-M44uIFSJjcfS-eaMPYeQT8C-AmPtWWJMKFEx4JXgICr5gaxAirbqFIg9smLQdhUTtToghyndMcaUaLqP5IALaFXXsBX5dzFsgxmzWQek9xjTnKidvUdH8SFjHE2gFsccS73HcVpkkzdYpET9FGm508GM5haHgtHJU7vpg4s4UjM6atwUMC0Oif7t84YaO2ek4XHYbqZ1MCn3lgacfxscenNM9r0JCU-e6xG5-fH9-vxXdXn18-L822VlRctz5cBzyW2t1q3lnVXKdFyCV7KpmapRWIseG0BsXQ3InVXlbCxzSvrOIIgj8mXnu43TnxlT1kNfHhnKJrB8UQPnAKLmtSro5__Qu2le1rJQTSNlLfliCDvKximliF5vYz-Y-KiB6SUrvctKl6z0kpWWpef02XleD-heO17CKQDfAalI4y3GN6PfdX0C2WSh6Q</recordid><startdate>20121201</startdate><enddate>20121201</enddate><creator>White, Alan D.</creator><creator>Othman, Diaa</creator><creator>Dawrant, Michael J.</creator><creator>Sohrabi, Soroush</creator><creator>Young, Alastair L.</creator><creator>Squire, Roly</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20121201</creationdate><title>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</title><author>White, Alan D. ; Othman, Diaa ; Dawrant, Michael J. ; Sohrabi, Soroush ; Young, Alastair L. ; Squire, Roly</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Catheterization, Central Venous - adverse effects</topic><topic>Catheterization, Central Venous - instrumentation</topic><topic>Catheters, Indwelling - adverse effects</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Original Article</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>White, Alan D.</creatorcontrib><creatorcontrib>Othman, Diaa</creatorcontrib><creatorcontrib>Dawrant, Michael J.</creatorcontrib><creatorcontrib>Sohrabi, Soroush</creatorcontrib><creatorcontrib>Young, Alastair L.</creatorcontrib><creatorcontrib>Squire, Roly</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric surgery international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>White, Alan D.</au><au>Othman, Diaa</au><au>Dawrant, Michael J.</au><au>Sohrabi, Soroush</au><au>Young, Alastair L.</au><au>Squire, Roly</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia</atitle><jtitle>Pediatric surgery international</jtitle><stitle>Pediatr Surg Int</stitle><addtitle>Pediatr Surg Int</addtitle><date>2012-12-01</date><risdate>2012</risdate><volume>28</volume><issue>12</issue><spage>1195</spage><epage>1199</epage><pages>1195-1199</pages><issn>0179-0358</issn><eissn>1437-9813</eissn><abstract>Purpose The aim of this study was to determine if there is a difference between complications for totally implantable central venous catheters (ports) and tunnelled external central venous catheters (external CVCs) that result in early removal of the central venous catheter (CVC) in children and adolescents with acute lymphoblastic leukaemia (ALL). Methods All children hospitalised between November 1996 and December 2007 with ALL who had a CVC were included retrospectively. We analysed data regarding the patient’s first CVC. Results We included 322 patients. 254 received a port and 68 received an external CVC. There were 102 CVC complications that required removal of the CVC prior to the completion of chemotherapy (65 in patients with ports, 37 in patients with external CVCs). Overall complications requiring CVC removal were significantly less likely to occur in the patient’s with ports ( p  &lt; 0.001). Ports were significantly less likely to require removal prior to the end of treatment overall ( p  &lt; 0.001) and for specific complications such as infection ( p  &lt; 0.001) and dislodgement ( p  = 0.001). However, when adjusted for disease severity there is no difference in premature CVC removal rates. Conclusion When patients are risk-stratified for disease severity there is no difference in rates of CVC removal prior to completion of treatment.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23178960</pmid><doi>10.1007/s00383-012-3213-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0179-0358
ispartof Pediatric surgery international, 2012-12, Vol.28 (12), p.1195-1199
issn 0179-0358
1437-9813
language eng
recordid cdi_proquest_miscellaneous_1221135258
source Springer Link
subjects Adolescent
Catheterization, Central Venous - adverse effects
Catheterization, Central Venous - instrumentation
Catheters, Indwelling - adverse effects
Child
Child, Preschool
Equipment Design
Female
Humans
Infant
Male
Medicine
Medicine & Public Health
Original Article
Pediatric Surgery
Pediatrics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Retrospective Studies
Surgery
Young Adult
title Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A15%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implantable%20versus%20cuffed%20external%20central%20venous%20catheters%20for%20the%20management%20of%20children%20and%20adolescents%20with%20acute%20lymphoblastic%20leukaemia&rft.jtitle=Pediatric%20surgery%20international&rft.au=White,%20Alan%20D.&rft.date=2012-12-01&rft.volume=28&rft.issue=12&rft.spage=1195&rft.epage=1199&rft.pages=1195-1199&rft.issn=0179-0358&rft.eissn=1437-9813&rft_id=info:doi/10.1007/s00383-012-3213-4&rft_dat=%3Cproquest_cross%3E1221135258%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-d1f242c58b7c29c88a9241f8465085e3ccefe61ee7d51e2dc81e26c0d84f9ae13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1266445421&rft_id=info:pmid/23178960&rfr_iscdi=true